mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone from the recurrent acquisition of CDKN2AOver the past a long time, the number of sufferers referred for allogeneic hematopoietic mobile transplantation has dropped drastically,133 but the method need to be advised to youthful/suit clients in whom BCR/BCL2 inhibit